https://twitter.com/pharmaphorum/status/1721493907165298994SGLT2-based combination therapies from @AstraZeneca and @Boehringer raise the prospect of improved therapy for chronic #kidneydisease. #KidneyWk https://bit.ly/3QJJbKo https://bit.ly/3QujfkJ
— pharmaphorum (@pharmaphorum) Nov 6, 2023
Monday, November 6, 2023
@pharmaphorum
http://twitter.com/pharmaphorum
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment